Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gujarat Kidney And Super SpecialityNSE:GKSL +0.22%18 Return-on-Tangible-Asset is 9.75% as of Mar. 2026, which is 16% below its 10-year median of 11.62. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Gujarat Kidney And Super Speciality ranks better than 87.04% on this metric.
The historical rank and industry rank for Gujarat Kidney And Super Speciality's Return-on-Tangible-Asset or its related term are showing as below:
NSE:GKSL'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 10.39 Med: 11.62 Max: 14.98
Current: 12.35
During the past 4 years, Gujarat Kidney And Super Speciality's highest Return-on-Tangible-Asset was 14.98%. The lowest was 10.39%. And the median was 11.62%.
NSE:GKSL's Return-on-Tangible-Asset is ranked better than 87.04% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 2.51
vs NSE:GKSL: 12.35
Gujarat Kidney And Super Speciality (NSE:GKSL) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Gujarat Kidney And Super Speciality Return-on-Tangible-Asset Related Terms
Gujarat Kidney And Super Speciality Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gujarat Kidney And Super Speciality Return-on-Tangible-Asset Chart
Gujarat Kidney And Super Speciality Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Return-on-Tangible-Asset
10.39
14.98
12.59
10.65
Gujarat Kidney And Super Speciality Quarterly Data
NSE:GKSL vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Gujarat Kidney And Super Speciality's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gujarat Kidney And Super Speciality Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gujarat Kidney And Super Speciality's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Gujarat Kidney And Super Speciality's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 9.75% mean?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a Return-on-Tangible-Asset of 9.75% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Gujarat Kidney And Super Speciality and its competitors. This is 16% below median its historical median of 11.62. Over the past decade, Gujarat Kidney And Super Speciality's Return-on-Tangible-Asset has ranged from 10.39 to 14.98. According to the industry distribution chart, Gujarat Kidney And Super Speciality ranks #88 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 13%.
Is Gujarat Kidney And Super Speciality's Return-on-Tangible-Asset too high?
Gujarat Kidney And Super Speciality's current Return-on-Tangible-Asset of 9.75% is 16% below median its 10-year median of 11.62. Over the past 10 years, this metric has ranged from a low of 10.39 to a high of 14.98. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.51. Gujarat Kidney And Super Speciality's value of 9.75% is 288.4% above this industry median. Based on the distribution chart, Gujarat Kidney And Super Speciality ranks #88 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gujarat Kidney And Super Speciality ranks #88 out of 679 companies for Return-on-Tangible-Asset. This places Gujarat Kidney And Super Speciality in the top 13% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.51. Gujarat Kidney And Super Speciality's value of 9.75% is 288.4% above this benchmark. Historically, Gujarat Kidney And Super Speciality's own Return-on-Tangible-Asset has ranged from 10.39 to 14.98 over the past decade. While the company's 10-year median is 11.62 vs. the industry median of 2.51, Gujarat Kidney And Super Speciality has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Kidney And Super Speciality's current Return-on-Tangible-Asset of 9.75% is 288.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Gujarat Kidney And Super Speciality and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Kidney And Super Speciality's current Return-on-Tangible-Asset is 9.75%, which is 16% below median its own 10-year median of 11.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current Return-on-Tangible-Asset of 9.75%. The current Return-on-Tangible-Asset is 9.75%, which is 16% below median its 10-year median of 11.62 and 288.4% above the Healthcare Providers & Services industry median of 2.51. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current Return-on-Tangible-Asset is 9.75% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score
Get the complete analysis for NSE:GKSL
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GKSL has been successfully added to your 
